AOD-9604, sometimes called the fat-burning peptide, showed limited promise in animal studies but has failed to demonstrate consistent results in people, leading the FDA to explicitly state it is not an approved treatment (FDA on unapproved drugs)
Using one of our convenient finger-prick blood tests at home provides the hard data needed to decide if injections are truly necessary, helping you choose the right treatment plan without guesswork
Ingold I, Aichler M, Yefremova E, Roveri A, Buday K, Doll S et al
These hepatic improvements, which may be associated with cotadutide's glucagon activity, indicate its potential as a therapeutic option for nonalcoholic steatohepatitis (NASH)
Remember to consult your healthcare provider before starting new supplements, especially if you have medical conditions or take medication.